Gianmarco Mastrogiovanni

Gianmarco Mastrogiovanni has a diverse work experience that spans over several years. Gianmarco currently holds the role of Team Leader in Cell Type Development at bit.bio, a position they have held since November 2022. Prior to this, they served as a Senior Scientist and Team Lead in Cell Type Development at the same company from September 2021 to November 2022. In addition, they worked as a Senior Scientist at bit.bio from November 2020 to September 2021.

Before joining bit.bio, Gianmarco Mastrogiovanni worked as a Senior Scientist in Cell Biology at Lightcast Discovery from October 2019 to November 2020. Gianmarco also gained experience as a Postdoctoral Researcher at The Wellcome / Cancer Research UK Gurdon Institute from August 2017 to September 2019.

Earlier in their career, Gianmarco Mastrogiovanni completed a PhD in Genetics as a PhD Student at the Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute from April 2014 to August 2017. Gianmarco also undertook internships in Experimental Oncology at Azienda Ospedaliera Universitaria Senese - Siena from September 2012 to September 2013, in Pain Physiology at the University of Siena from June 2012 to November 2012, and in Microbiology at Azienda Ospedaliera Universitaria Senese - Siena from February 2011 to September 2011.

Gianmarco Mastrogiovanni completed their education with a Doctor of Philosophy - PhD degree in Genetics from the University of Cambridge, from 2014 to 2017. Prior to that, they earned a Master's degree in Medical Biotechnologies from Università degli Studi di Siena, from 2011 to 2013. Gianmarco also holds a Bachelor's degree in Biotechnologies from the same university, which they obtained from 2008 to 2011. In terms of additional certifications, they obtained an IELTS Academic 7.5 certification from the British Council in December 2013. Gianmarco also holds a Certificate of competence of English language level B2, the institution from which is the University of Siena. Moreover, Gianmarco has a Preliminary English Test PET but the institution is the University of Cambridge (no information is available about when they obtained these two certifications).